DINA ABDELSLAME: Open Payments
NPI 1437802758 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 12 payments from 8 companies in 2025. Trend: 2023 $188 · 2024 $64 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 3 | $44 |
| Exeltis, USA Inc. | 2 | $40 |
| MILLICENT US INC | 2 | $37 |
| Lilly USA, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $17 |
| OptumHealth Care Solutions, LLC | 1 | $14 |
| Organon LLC | 1 | $13 |
Products named: SLYND, FEMLYV, ZEPBOUND, LILETTA, Phexxi, VIVIFY HEALTH CARE TEAM PORTAL 001, NEXPLANON.
Industry payments across NJ — which companies pay providers there.
